Category: Reagents

Reference: SM61-25
€0.00 (tax incl.)
As a Topo I inhibitor, Irinotecan inhibits the religation step of the enzyme's normal action, inducing single stranded DNA breaks. These single stranded breaks are then converted to double-stranded breaks within the...
Reference: SM61-100
€0.00 (tax incl.)
As a Topo I inhibitor, Irinotecan inhibits the religation step of the enzyme's normal action, inducing single stranded DNA breaks. These single stranded breaks are then converted to double-stranded breaks within the...
Reference: SM61-250
€0.00 (tax incl.)
As a Topo I inhibitor, Irinotecan inhibits the religation step of the enzyme's normal action, inducing single stranded DNA breaks. These single stranded breaks are then converted to double-stranded breaks within the...
Reference: SM61-1000
€0.00 (tax incl.)
As a Topo I inhibitor, Irinotecan inhibits the religation step of the enzyme's normal action, inducing single stranded DNA breaks. These single stranded breaks are then converted to double-stranded breaks within the...
Reference: SM39-2
€0.00 (tax incl.)
IWP-2 promotes cardiomyocyte differentiation from human pluripotent stem cells (hPSC). This small molecule also suppresses self-renewal in mouse embryonic stem cells and supports their conversion to epiblast-like stem...
Reference: SM39-10
€0.00 (tax incl.)
IWP-2 promotes cardiomyocyte differentiation from human pluripotent stem cells (hPSC). This small molecule also suppresses self-renewal in mouse embryonic stem cells and supports their conversion to epiblast-like stem...
Reference: SM39-50
€0.00 (tax incl.)
IWP-2 promotes cardiomyocyte differentiation from human pluripotent stem cells (hPSC). This small molecule also suppresses self-renewal in mouse embryonic stem cells and supports their conversion to epiblast-like stem...
Reference: SM39-100
€0.00 (tax incl.)
IWP-2 promotes cardiomyocyte differentiation from human pluripotent stem cells (hPSC). This small molecule also suppresses self-renewal in mouse embryonic stem cells and supports their conversion to epiblast-like stem...
Reference: SM62-1
€0.00 (tax incl.)
JNJ-10198409 displays potent antiproliferative properties in human tumor cell lines and antiangiogenic activity.
Reference: SM62-5
€0.00 (tax incl.)
JNJ-10198409 displays potent antiproliferative properties in human tumor cell lines and antiangiogenic activity.
Reference: SM62-50
€0.00 (tax incl.)
JNJ-10198409 displays potent antiproliferative properties in human tumor cell lines and antiangiogenic activity.
Reference: SM64-2
€0.00 (tax incl.)
KY02111 promotes differentiation of human pluripotent stem cells (hPSC) to cardiomyocytes by inhibiting Wnt signaling in hPSC in a manner that is distinct from that of previously studied Wnt inhibitors. The...
Reference: SM64-10
€0.00 (tax incl.)
KY02111 promotes differentiation of human pluripotent stem cells (hPSC) to cardiomyocytes by inhibiting Wnt signaling in hPSC in a manner that is distinct from that of previously studied Wnt inhibitors. The...
Reference: SM64-50
€0.00 (tax incl.)
KY02111 promotes differentiation of human pluripotent stem cells (hPSC) to cardiomyocytes by inhibiting Wnt signaling in hPSC in a manner that is distinct from that of previously studied Wnt inhibitors. The...
Reference: SM23-1
€0.00 (tax incl.)
LDN193189 inhibits ectopic ossification and it is a potential agent in the treatment of NSCLC lung tumors, showing significant in-vivo clinical utility. LDN193189 has been used to reduce ectopic ossification in a...
Reference: SM23-5
€0.00 (tax incl.)
LDN193189 inhibits ectopic ossification and it is a potential agent in the treatment of NSCLC lung tumors, showing significant in-vivo clinical utility. LDN193189 has been used to reduce ectopic ossification in a...
Reference: SM23-10
€0.00 (tax incl.)
LDN193189 inhibits ectopic ossification and it is a potential agent in the treatment of NSCLC lung tumors, showing significant in-vivo clinical utility. LDN193189 has been used to reduce ectopic ossification in a...
Reference: SM23-50
€0.00 (tax incl.)
LDN193189 inhibits ectopic ossification and it is a potential agent in the treatment of NSCLC lung tumors, showing significant in-vivo clinical utility. LDN193189 has been used to reduce ectopic ossification in a...
Reference: SM24-10
€0.00 (tax incl.)
LY294002 inhibits cell proliferation of choroidal melanoma OCM-1 cells. In mouse embryonic stem cells, LY294002 prevents self-renewal by inhibiting LIF2.
Reference: SM24-50
€0.00 (tax incl.)
LY294002 inhibits cell proliferation of choroidal melanoma OCM-1 cells. In mouse embryonic stem cells, LY294002 prevents self-renewal by inhibiting LIF2.
Reference: SM24-100
€0.00 (tax incl.)
LY294002 inhibits cell proliferation of choroidal melanoma OCM-1 cells. In mouse embryonic stem cells, LY294002 prevents self-renewal by inhibiting LIF2.
Reference: SM24-1000
€0.00 (tax incl.)
LY294002 inhibits cell proliferation of choroidal melanoma OCM-1 cells. In mouse embryonic stem cells, LY294002 prevents self-renewal by inhibiting LIF2.
Reference: SM25-1
€0.00 (tax incl.)
Notch signaling is a pathway known to regulate both differentiation and proliferation of cells in diverse adult tissues. LY411575 has been shown to promote goblet cell differentiation in mice intestine. It has also...
Reference: SM25-5
€0.00 (tax incl.)
Notch signaling is a pathway known to regulate both differentiation and proliferation of cells in diverse adult tissues. LY411575 has been shown to promote goblet cell differentiation in mice intestine. It has also...
Reference: SM25-10
€0.00 (tax incl.)
Notch signaling is a pathway known to regulate both differentiation and proliferation of cells in diverse adult tissues. LY411575 has been shown to promote goblet cell differentiation in mice intestine. It has also...
Reference: SM25-50
€0.00 (tax incl.)
Notch signaling is a pathway known to regulate both differentiation and proliferation of cells in diverse adult tissues. LY411575 has been shown to promote goblet cell differentiation in mice intestine. It has also...
Reference: SM25-100
€0.00 (tax incl.)
Notch signaling is a pathway known to regulate both differentiation and proliferation of cells in diverse adult tissues. LY411575 has been shown to promote goblet cell differentiation in mice intestine. It has also...
Reference: SM69-25
€0.00 (tax incl.)
NVP-BEZ235 shows high target specificity and demonstrates antiproliferative activity against tumor cell lines in animal models of cancer.
Reference: SM69-100
€0.00 (tax incl.)
NVP-BEZ235 shows high target specificity and demonstrates antiproliferative activity against tumor cell lines in animal models of cancer.
Reference: SM69-1000
€0.00 (tax incl.)
NVP-BEZ235 shows high target specificity and demonstrates antiproliferative activity against tumor cell lines in animal models of cancer.
Reference: SM26-2
€0.00 (tax incl.)
PD0325901 has potential antineoplastic activity. This molecule inhibits the growth of melanoma cell lines in-vitro and in-vivo.
Reference: SM26-10
€0.00 (tax incl.)
PD0325901 has potential antineoplastic activity. This molecule inhibits the growth of melanoma cell lines in-vitro and in-vivo.
Reference: SM26-25
€0.00 (tax incl.)
PD0325901 has potential antineoplastic activity. This molecule inhibits the growth of melanoma cell lines in-vitro and in-vivo.
Reference: SM26-100
€0.00 (tax incl.)
PD0325901 has potential antineoplastic activity. This molecule inhibits the growth of melanoma cell lines in-vitro and in-vivo.
Reference: SM27-2
€0.00 (tax incl.)
PD173074 inhibits proliferation and differentiation of oligodendrocyte progenitors. PD173074 also blocks tumor growth in H510 and H69 SCLC xenograft models.
Reference: SM27-10
€0.00 (tax incl.)
PD173074 inhibits proliferation and differentiation of oligodendrocyte progenitors. PD173074 also blocks tumor growth in H510 and H69 SCLC xenograft models.
Reference: SM27-25
€0.00 (tax incl.)
PD173074 inhibits proliferation and differentiation of oligodendrocyte progenitors. PD173074 also blocks tumor growth in H510 and H69 SCLC xenograft models.
Reference: SM27-100
€0.00 (tax incl.)
PD173074 inhibits proliferation and differentiation of oligodendrocyte progenitors. PD173074 also blocks tumor growth in H510 and H69 SCLC xenograft models.
Reference: SM73-2
€0.00 (tax incl.)
PD184352 has anti-cancer properties, suppresses the ERK pathway, and has been used along with other classes of inhibitors to establish embryonic stem cell (ESC) lines.
Reference: SM73-10
€0.00 (tax incl.)
PD184352 has anti-cancer properties, suppresses the ERK pathway, and has been used along with other classes of inhibitors to establish embryonic stem cell (ESC) lines.
Reference: SM73-25
€0.00 (tax incl.)
PD184352 has anti-cancer properties, suppresses the ERK pathway, and has been used along with other classes of inhibitors to establish embryonic stem cell (ESC) lines.
Reference: SM73-100
€0.00 (tax incl.)
PD184352 has anti-cancer properties, suppresses the ERK pathway, and has been used along with other classes of inhibitors to establish embryonic stem cell (ESC) lines.
Reference: SM28-2
€0.00 (tax incl.)
PD98059 inhibits cell growth and reverses the phenotype of ras-transformed BALB3T3 mouse fibroblasts and rat kidney cells. PD98059 inhibits cell growth and proliferation in acute myelogenous leukemia (AML) cell lines...
Reference: SM28-10
€0.00 (tax incl.)
PD98059 inhibits cell growth and reverses the phenotype of ras-transformed BALB3T3 mouse fibroblasts and rat kidney cells. PD98059 inhibits cell growth and proliferation in acute myelogenous leukemia (AML) cell lines...
Reference: SM28-25
€0.00 (tax incl.)
PD98059 inhibits cell growth and reverses the phenotype of ras-transformed BALB3T3 mouse fibroblasts and rat kidney cells. PD98059 inhibits cell growth and proliferation in acute myelogenous leukemia (AML) cell lines...
Reference: SM28-50
€0.00 (tax incl.)
PD98059 inhibits cell growth and reverses the phenotype of ras-transformed BALB3T3 mouse fibroblasts and rat kidney cells. PD98059 inhibits cell growth and proliferation in acute myelogenous leukemia (AML) cell lines...
Reference: SM74-2
€0.00 (tax incl.)
In blast cells, PI-103 inhibits leukemic proliferation, the clonogenicity of leukemic progenitors and induces mitochondrial apoptosis, especially in the compartment containing leukemic stem cells.
Reference: SM74-10
€0.00 (tax incl.)
In blast cells, PI-103 inhibits leukemic proliferation, the clonogenicity of leukemic progenitors and induces mitochondrial apoptosis, especially in the compartment containing leukemic stem cells.
Reference: SM74-25
€0.00 (tax incl.)
In blast cells, PI-103 inhibits leukemic proliferation, the clonogenicity of leukemic progenitors and induces mitochondrial apoptosis, especially in the compartment containing leukemic stem cells.
Reference: SM74-100
€0.00 (tax incl.)
In blast cells, PI-103 inhibits leukemic proliferation, the clonogenicity of leukemic progenitors and induces mitochondrial apoptosis, especially in the compartment containing leukemic stem cells.
Reference: SM29-2.5
€0.00 (tax incl.)
Pifithrin μ rescues cells from lethal γ-irradiation-induced cell death.
Reference: SM29-10
€0.00 (tax incl.)
Pifithrin μ rescues cells from lethal γ-irradiation-induced cell death.
Reference: SM29-50
€0.00 (tax incl.)
Pifithrin μ rescues cells from lethal γ-irradiation-induced cell death.
Reference: SM76-2
€0.00 (tax incl.)
This molecule inhibits production of PIP2 and PIP3 in adipocytes, phosphorylation of Akt and also activation of mTORC1. It has been studied that PIK-75 significantly reduces leukemia burden and increases the survival...
Reference: SM76-10
€0.00 (tax incl.)
This molecule inhibits production of PIP2 and PIP3 in adipocytes, phosphorylation of Akt and also activation of mTORC1. It has been studied that PIK-75 significantly reduces leukemia burden and increases the survival...
Reference: SM76-50
€0.00 (tax incl.)
This molecule inhibits production of PIP2 and PIP3 in adipocytes, phosphorylation of Akt and also activation of mTORC1. It has been studied that PIK-75 significantly reduces leukemia burden and increases the survival...
Reference: SM76-100
€0.00 (tax incl.)
This molecule inhibits production of PIP2 and PIP3 in adipocytes, phosphorylation of Akt and also activation of mTORC1. It has been studied that PIK-75 significantly reduces leukemia burden and increases the survival...
Reference: SM78-2
€0.00 (tax incl.)
Plerixafor is one of the most efficient bone marrow stem cell mobilizers. Plerixafor results in the rapid and reversible mobilization of hematopoietic stem cells (HSC) into the peripheral circulation and is...
Reference: SM78-10
€0.00 (tax incl.)
Plerixafor is one of the most efficient bone marrow stem cell mobilizers. Plerixafor results in the rapid and reversible mobilization of hematopoietic stem cells (HSC) into the peripheral circulation and is...
Reference: SM78-25
€0.00 (tax incl.)
Plerixafor is one of the most efficient bone marrow stem cell mobilizers. Plerixafor results in the rapid and reversible mobilization of hematopoietic stem cells (HSC) into the peripheral circulation and is...
Reference: SM78-50
€0.00 (tax incl.)
Plerixafor is one of the most efficient bone marrow stem cell mobilizers. Plerixafor results in the rapid and reversible mobilization of hematopoietic stem cells (HSC) into the peripheral circulation and is...
Reference: SM78-200
€0.00 (tax incl.)
Plerixafor is one of the most efficient bone marrow stem cell mobilizers. Plerixafor results in the rapid and reversible mobilization of hematopoietic stem cells (HSC) into the peripheral circulation and is...

PP1

Reference: SM79-1
€0.00 (tax incl.)
PP1 inhibits anti-CD3-induced T cell tyrosine phosphorylation, TcR-induced T cell proliferation, and IL-2 gene induction. PP1 has been demonstrated to reduce the expression of vascular endothelial growth factor...

PP1

Reference: SM79-5
€0.00 (tax incl.)
PP1 inhibits anti-CD3-induced T cell tyrosine phosphorylation, TcR-induced T cell proliferation, and IL-2 gene induction. PP1 has been demonstrated to reduce the expression of vascular endothelial growth factor...

PP1

Reference: SM79-25
€0.00 (tax incl.)
PP1 inhibits anti-CD3-induced T cell tyrosine phosphorylation, TcR-induced T cell proliferation, and IL-2 gene induction. PP1 has been demonstrated to reduce the expression of vascular endothelial growth factor...
Reference: SM80-5
€0.00 (tax incl.)
PTK787 inhibits VEGFR-dependent tumor angiogenesis and EGFR- and RET-dependent tumor cell proliferation and survival. It shows the anti-proliferation effect by inhibiting thymidine incorporation induced by VEGF in...
Reference: SM80-25
€0.00 (tax incl.)
PTK787 inhibits VEGFR-dependent tumor angiogenesis and EGFR- and RET-dependent tumor cell proliferation and survival. It shows the anti-proliferation effect by inhibiting thymidine incorporation induced by VEGF in...
Reference: SM80-100
€0.00 (tax incl.)
PTK787 inhibits VEGFR-dependent tumor angiogenesis and EGFR- and RET-dependent tumor cell proliferation and survival. It shows the anti-proliferation effect by inhibiting thymidine incorporation induced by VEGF in...
Reference: SM30-1
€0.00 (tax incl.)
Purmorphamine has been shown to induce osteogenesis in bone tissue as well as influencing growth and differentiation of neurons in the brain. The EC50 value for differentiation of C3H10T1/2 cells based on alkaline...
Reference: SM30-5
€0.00 (tax incl.)
Purmorphamine has been shown to induce osteogenesis in bone tissue as well as influencing growth and differentiation of neurons in the brain. The EC50 value for differentiation of C3H10T1/2 cells based on alkaline...
Reference: SM30-10
€0.00 (tax incl.)
Purmorphamine has been shown to induce osteogenesis in bone tissue as well as influencing growth and differentiation of neurons in the brain. The EC50 value for differentiation of C3H10T1/2 cells based on alkaline...
Reference: SM83-5
€0.00 (tax incl.)
Rapamycin is a potent immunosuppressant and it has anticancer activity. It induces autophagy in yeast and mammalian cell lines. It is unique in its ability to inhibit lymphokine induced cell proliferation at the G1...
Reference: SM83-25
€0.00 (tax incl.)
Rapamycin is a potent immunosuppressant and it has anticancer activity. It induces autophagy in yeast and mammalian cell lines. It is unique in its ability to inhibit lymphokine induced cell proliferation at the G1...
Reference: SM83-50
€0.00 (tax incl.)
Rapamycin is a potent immunosuppressant and it has anticancer activity. It induces autophagy in yeast and mammalian cell lines. It is unique in its ability to inhibit lymphokine induced cell proliferation at the G1...
Reference: SM83-100
€0.00 (tax incl.)
Rapamycin is a potent immunosuppressant and it has anticancer activity. It induces autophagy in yeast and mammalian cell lines. It is unique in its ability to inhibit lymphokine induced cell proliferation at the G1...
Reference: SM83-1000
€0.00 (tax incl.)
Rapamycin is a potent immunosuppressant and it has anticancer activity. It induces autophagy in yeast and mammalian cell lines. It is unique in its ability to inhibit lymphokine induced cell proliferation at the G1...
Reference: SM84-2
€0.00 (tax incl.)
Reboxetine stimulates neural stem cell (NSC) expansion.
Reference: SM84-10
€0.00 (tax incl.)
Reboxetine stimulates neural stem cell (NSC) expansion.
Reference: SM84-25
€0.00 (tax incl.)
Reboxetine stimulates neural stem cell (NSC) expansion.
Reference: SM84-100
€0.00 (tax incl.)
Reboxetine stimulates neural stem cell (NSC) expansion.
Reference: SM85-1
€0.00 (tax incl.)
Reversine is the first organic molecule that has been demonstrated to reverse the cellular differentiation process. It is shown to induce mouse C2C12 myoblast cells to become multipotent mesenchymal progenitor cells,...
Reference: SM85-5
€0.00 (tax incl.)
Reversine is the first organic molecule that has been demonstrated to reverse the cellular differentiation process. It is shown to induce mouse C2C12 myoblast cells to become multipotent mesenchymal progenitor cells,...
Reference: SM85-10
€0.00 (tax incl.)
Reversine is the first organic molecule that has been demonstrated to reverse the cellular differentiation process. It is shown to induce mouse C2C12 myoblast cells to become multipotent mesenchymal progenitor cells,...
Reference: SM31-2
€0.00 (tax incl.)
RG108 inhibits human tumor cell line (HCT116, NALM-6) proliferation and increased doubling time in culture.
Reference: SM31-10
€0.00 (tax incl.)
RG108 inhibits human tumor cell line (HCT116, NALM-6) proliferation and increased doubling time in culture.
Reference: SM31-50
€0.00 (tax incl.)
RG108 inhibits human tumor cell line (HCT116, NALM-6) proliferation and increased doubling time in culture.
Reference: SM86-10
€0.00 (tax incl.)
Rosiglitazone is antidiabetic, working as an insulin sensitizer by binding to the PPAR gamma receptors in fat cells and making the cells more responsive to insulin. Rosiglitazone induced adipocyte differentiation in...
Reference: SM86-50
€0.00 (tax incl.)
Rosiglitazone is antidiabetic, working as an insulin sensitizer by binding to the PPAR gamma receptors in fat cells and making the cells more responsive to insulin. Rosiglitazone induced adipocyte differentiation in...
Reference: SM86-200
€0.00 (tax incl.)
Rosiglitazone is antidiabetic, working as an insulin sensitizer by binding to the PPAR gamma receptors in fat cells and making the cells more responsive to insulin. Rosiglitazone induced adipocyte differentiation in...
Reference: SM86-1000
€0.00 (tax incl.)
Rosiglitazone is antidiabetic, working as an insulin sensitizer by binding to the PPAR gamma receptors in fat cells and making the cells more responsive to insulin. Rosiglitazone induced adipocyte differentiation in...
Reference: SM87-2
€0.00 (tax incl.)
JAK inhibition with ruxolitinib could work as pretreatment for allogeneic stem cell transplantation in myelofibrosis. Ruxolitinib inhibits erythropoiesis from induced pluripotent stem cells (iPSC), but has less...
Reference: SM87-10
€0.00 (tax incl.)
JAK inhibition with ruxolitinib could work as pretreatment for allogeneic stem cell transplantation in myelofibrosis. Ruxolitinib inhibits erythropoiesis from induced pluripotent stem cells (iPSC), but has less...
Reference: SM87-25
€0.00 (tax incl.)
JAK inhibition with ruxolitinib could work as pretreatment for allogeneic stem cell transplantation in myelofibrosis. Ruxolitinib inhibits erythropoiesis from induced pluripotent stem cells (iPSC), but has less...
Reference: SM87-100
€0.00 (tax incl.)
JAK inhibition with ruxolitinib could work as pretreatment for allogeneic stem cell transplantation in myelofibrosis. Ruxolitinib inhibits erythropoiesis from induced pluripotent stem cells (iPSC), but has less...
Reference: SM88-10
€0.00 (tax incl.)
Experiments suggest that SAHA causes morphological changes, such as enlargement and flattening of the cytoplasm, resulting in growth inhibition. SAHA alters gene transcription and induces cell cycle arrest and/or...
Reference: SM88-50
€0.00 (tax incl.)
Experiments suggest that SAHA causes morphological changes, such as enlargement and flattening of the cytoplasm, resulting in growth inhibition. SAHA alters gene transcription and induces cell cycle arrest and/or...
Reference: SM88-250
€0.00 (tax incl.)
Experiments suggest that SAHA causes morphological changes, such as enlargement and flattening of the cytoplasm, resulting in growth inhibition. SAHA alters gene transcription and induces cell cycle arrest and/or...
Reference: SM88-500
€0.00 (tax incl.)
Experiments suggest that SAHA causes morphological changes, such as enlargement and flattening of the cytoplasm, resulting in growth inhibition. SAHA alters gene transcription and induces cell cycle arrest and/or...
Reference: SM88-1000
€0.00 (tax incl.)
Experiments suggest that SAHA causes morphological changes, such as enlargement and flattening of the cytoplasm, resulting in growth inhibition. SAHA alters gene transcription and induces cell cycle arrest and/or...
Reference: SM32-2
€0.00 (tax incl.)
SB203580 inhibits the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC50 of 3 - 5 μM. SB203580 suppresses the development of endometriosis by down-regulating...

Menu

Settings